ChemoCentryx
CCXI
#3567
Rank
HK$29.26 B
Marketcap
HK$406.91
Share price
0.00%
Change (1 day)
34.69%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): -HK$14.78

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -HK$14.79. In 2021 the company made an earnings per share (EPS) of -HK$14.79 a decrease over its 2020 EPS that were of -HK$6.34.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$14.78-0.12%
2021-HK$14.79133.33%
2020-HK$6.34-16.49%
2019-HK$7.5927.63%
2018-HK$5.95-305.41%
2017HK$2.90-142.53%
2016-HK$6.81-19.44%
2015-HK$8.45-0%
2014-HK$8.4513.68%
2013-HK$7.44-16.67%
2012-HK$8.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.17-689.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.64-171.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.72-226.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.16-858.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$86.02-681.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.19-486.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.25-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.49-299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$9.71-165.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel